national kidney foundation 2008 spring clinical meetings

A

1

A

National Kidney Foundation2008 Spring Clinical Meetings Abstracts

April 2-6, 2008Dallas, TX

CUTE KIDNEY INJURY/ICU MEDICINE

11 Exceptions to the Paradigms of Fractional Excretion of Urea in the Differential Diagnosis of AcuteRenal FailureArun Amatya, Mauro Braun, Rute Paixao, Beth Fromkin, and Diane SandyCleveland Clinic Florida (CCF), Weston, FL

12 Irreversible Acute Renal Failure? Not So FastHatem Amer and Nelson LeungMayo Clinic, Rochester, MN

27 Intracavitary Aminoglycosides and Acute Tubular NecrosisDoreen Bett, Ashfaq Balla, Alan Schned, and Clay BlockDartmouth Hitchcock Medical Center, Lebanon, NH

36 Outcome-Predictability of the Etiological Aki Categorization and the Novel Rifle ClassificationAlan Brijbassie,1,2Sajid George,1,2 Smriti Sharma,1,2 Jude Ojie,1,2 Kamyar Kalantar-Zadeh,3 andCsaba Kovesdy1

1VA Medical Center, Salem, VA; 2Carilion Clinic Roanoke VA; 3Harbor UCLA, Torrence, CA

43 Acute Interstitial Nephritis and PPIs: Case Report and Review of LiteratureMicah R. Chan, Alexander S. Yevzlin, Weixong Zhong, and Paul S. KellermanUniversity of Wisconsin Hospitals, Madison, WI

44 Calciphylaxis Responsive to Lanthanum Carbonate (Fosrenol) TherapyMicah R. Chan, Alexander S. Yevzlin, Molly Hinshaw, and Jonathan B. JafferyUniversity of Wisconsin and Affiliated Hospitals, Madison, WI

55 Minimal Change Disease (MCD) Presenting As Acute Kidney Injury And Nephrotic-RangeProteinuria Without EdemaArvind Datla, Fabio Aglieco, M. Atiq Dada, and Wilner SamsonUniversity of Connecticut

77 Outcomes of Acute Kidney Injury Associated With Inhibitors of Renin-Angiotensin SystemSajid Melvin George, Alan Brijbassie, Smriti Sharma, Jude Ojie, Kamyar Kalantar-Zadeh, andCsaba KovesdyVA Medical Center, Salem, VA Carilion Clinic, Roanoke, VA and Harbor UCLA, Torrance, CA

79 Acute Interstitial Nephritis (AIN) Secondary to Vancomycin. Case Report and Literature Reviewof Vancomycin Nephrotoxicity in Modern EraManish Gera,1 R. Jeevan,1 S. Dhar,1 and C.L. Phillips2

1Internal Medicine Nephrology Inc, Terre Haute, IN; 2I.U. Pathology, Indianapolis, IN

94 Survival of Elderly Patients with Acute Kidney Injury Requiring Continuous Renal ReplacementTherapyHaque, Ammar, Dall, Aaron, Hussain, Syed, and Regner, KevinMedical College of Wisconsin, Milwaukee, WI

13 Prevention of Contrast Nephropathy: Are Practice Patterns Congruent With Current Recommenda-tions?Praveen Kandula,1 Nishith Singh,1 and Sagar U Nigwekar2

1Southern Illinois University, Springfield, IL; 2Rochester General Hospital, Rochester, NY

merican Journal of Kidney Diseases, Vol 51, No 4 (April), 2008: pp A1-A98 A1

1

1

1

1

1

1

2

2

2

2

2

2

NKF 2008 Spring Clinical Meetings AbstractsA2

29 Acute and Reversible Vancomycin Nephrotoxicity: A Case SeriesMarco Ladino, Manju Alex, and Ivonne Hernandez SchulmanDivision of Nephrology and Hypertension, Veterans Affairs Medical Center and University ofMiami Miller School of Medicine, Miami, FL

34 Pilot Study of Brain Natriuretic Peptide (BNP) For the Prevention of Radiocontrast InducedNephropathy (RCIN) After Cardiac CatheterizationRakesh Lattupalli, Desikan Kamalakannan, Nancy Mesiha, Susan Steigerwalt, Robert Prov-enzano, Howard Rosman, and Quresh KhairullahDivision of Nephrology, St John Hospital and Medical Center, Detroit, MI

43 Oral Sodium Phosphate Laxative Associated Acute Renal FailureKelly Liang, Iasmina Craici, Kianoush Kashani, Hatem Amer, and John DillonMayo Clinic, Rochester, MN

56 Bilateral Adrenal Hemorrhage (BAH) – A Reversible Cause of Acite Renal Failure (ARF)Mand, Raminder, Desai, Chetainya, and Chaudhari, Ashok

80 Incidence, Etiology, and Outcomes of Hospital Acquired Acute Renal Failure (HAARF) in ElderlySubrahmanyam Nasika, Saurabh Kumar Goel, Robert Krinsky, Kalyana Janga, Suneeta Gadde,Sheldon Greenberg, and Winston LeeMaimonides Medical Center, Brooklyn, NY

84 Thyroxine for Acute Kidney Injury in Humans: A Systematic ReviewSagar U Nigwekar,1 Sankar D Navaneethan,2 and Giovanni FM Strippoli31Rochester General Hospital, Rochester, NY; 2University of Rochester, Rochester, NY; 3CochraneRenal Group, Australia

03 Proposed Pathophysiology of Acute Kidnet Injury Following Retrograde PyelographyVishwas Patel and Hanan FahmyUniversity of Illinois, Urbana, IL

09 Granulomatous Interstitial Nephritis Secondary to Carbamazepine Causing Acute Renal FailurePrashanth Podaralla,1 Nagaraju Sarabu,2 and Marcos Rothstein1

1Barnes Jewish Hospital, Washington University, St Louis, MO; 2St Luke’s Hospital, Chesterfield,MO

10 Clinical Utility of Renal Ultrasound in Acute Kidney InjuryAmber S. Podoll and Kevin W. FinkelUniversity of Texas Health Science Center, Houston, TX

11 Catastrophic Antiphospholipid Syndrome Due to Inadequate Anticoagulation Leading to EndStage Renal DiseaseChristopher R. Provenzano and Anjali AcharyaJacobi Medical Center, Albert Einstein College, Bronx, NY

18 A Retrospective Study on the Mortality of Bone Marrow Transplant Recipients with Severe AcuteKidney InjuryArchana Rao, Andrew Fenves, and Joseph FayBaylor University Medical Center, Department of Oncology and Division of Nephrology, Dallas,TX

36 Deferiprone Ameliorates Cisplatin Injury to Renal Tubular Epithelial CellsSudhir V. Shah, Xiaoying Wang, Eugene O. Apostolov, and Alexei G. BasnakianUniversity of Arkansas for Medical Sciences & Central Arkansas Veterans Healthcare System,
Little Rock, AR

2

2

D

1

1

2

E

1

1

1

NKF 2008 Spring Clinical Meetings Abstracts A3

42 A Rare Case of Lunesta (Eszopiclone) Induced Acute Interstitial NephritisAlok Silodia, Robert N.Pursell, and Richard W. SnyderDepartment of Nephrology, St Lukes Hospital and Health Network, Bethlehem, PA

81 Acute Renal Failure Caused By Spontaneous Acute Tumor Lysis Syndrome from Uterine SarcomaPraveen R. Yalamanchili, Sumanth Daram, and Ashok KondurPeoria, AZ

IABETES

12 Emphysematous Pyelonephritis Not Identified on Routine Renal UltrasoundSarika Kadam,1 Satyarth Kulshrestha,2 Edwin Anand,3 Leon Kurtz,4 Louis Eichel,5 and JohnKevin Hix6

1,2,3,4,6Dept of Medicine; 5Dept of Urology at Rochester General Hospital, Rochester, NY

88 Effect of a Behavioral Modification Program on Proteinuria in Those with Type 2 DiabetesMatthew Novak, Beth Piraino, Dianxu Ren, and Mary Ann SevickUniversity of Pittsburgh School of Medicine, Pittsburgh, PA.

61 Pioglitazone Reduces Renal Fibrosis in a Rat Model of Type 2 DiabetesToblli Jorge,1 Ferrini Monica G,2 Cao Gabriel,1 Vernet Dolores,2 Angerosa Margarita,1 andGonzalez Cadavid Nestor F2

1Lab. of Experimental Medicine, Hospital Alemán, Buenos Aires, Argentina; 2LA BioMed atHarbor-UCLA Medical Center, Torrance, CA

LECTROLYTE AND ACID BASE ABNORMALITIES

10 Hypokalemia Associated With Carcinoid Tumor of the Thymus and Complicated by BilateralAdrenal HemorrhageAmmar Almehmi,1 Shahzad Shafique, Amer Malas, and Samar Sankari1Kansas University Medical Center, Kansas City, KS

33 Heterologous Downregulation of Vasopressin Type 2 Receptor is Induced By TransferrinBouley, R., Nunes, P., and Brown, D.Program in Membrane Biology, Nephrology Division, Massachusetts General Hospital, Boston,MA

65 Factitious Hyperphosphatemia Due to Sample Contamination with Heparin in an Arterial LineZiad El-Zoghby,1 Kevin Regner,1 Mark Keegan,2 and Edward Casey1

Divisions of 1Nephrology and 2Critical Care, Mayo Clinic, Rochester, MN

88 Acquired Fanconi Syndrome and Severe Hypophosphatemia after Exposure to Bee VenomGibbons R and Salahuddin S

44 Refractory Hypokalemia: A Case of Topiramate-Induced Renal Tubular Acidosis (RTA)Kelly Liang, Stephen Erickson, John Dillon, and Suzanne NorbyMayo Clinic, Rochester, MN

54 Familial Hypomagnesemia with Secondary Hypocalcemia Caused By TRPM6 Gene MutationsRavi K. Mallavarapu and Stanley T. PeskoeMercer University School of Medicine, Macon, GA

71 Renal Tubular Acidosis with Fanconi Syndrome Associated with TenofovirBrindusa Mocanu and Brant Holt
University of Tennessee at Chattanooga, TN

1

2

2

E


72 Metformin Associated Lactic Acidosis: The Marshfield Clinic ExperienceFalgun Modhia, Douglas P. Duffy, Michael D. Hammeke, and Narayana S. MuraliMarshfield Clinic, Marshfield, WI

13 Metformin Associated Lactic Acidosis (MALA) Presenting As Myocardial Infarction in a ChronicDialysis PatientChris Provenzano and Anjali AcharyaJacobi Medical Center, Albert Einstein Collage, Bronx, NY

31 Hemodialysis for Metformin-Associated Lactic AcidosisErdal Sarac, Hui Zhang, Thomas Detesco, and Hilmer NegreteDepartment of Medicine, St Elizabeth Hospital, Youngstown, OH and Northeastern OhioUniversities College of Medicine, Rootstown, OH

PIDEMIOLOGY/OUTCOMES

2 Serum Phosphate Levels and Mortality in Patients with Normal Renal Function AttendingInner-City Outpatient ClinicsMatthew Abramowitz, William Southern, Irwin Lotwin, Maria Coco, Thomas Hostetter, andMichal L. MelamedAlbert Einstein College of Medicine, Bronx, NY

13 A Systematic Review and Meta-Analysis: The Use of Plasma Exchange for Treatment of AcuteRenal Failure in Multiple MyelomaAshok Ammula,1 Jonathan Sosnov,2 Adam Segal,1 and Joline Chen1

1Renal Section, Department of Medicine, Boston University, Boston, MA; 2Division of Nephrologyand Hypertension, Miller School of Medicine, University of Miami, Miami, FL

23 Prevalence of Chronic Kidney Disease (CKD) In the Hospital SettingArie Barlev,1 Sidney Thornton,2 John Holmen,2 and Anthony G. Bower1

1Amgen Inc, Thousand Oaks, CA; 2Intermountain Healthcare, Salt Lake City, UT

32 Effect of Vitamin D3 Supplementation On Bone Mineral Density In Chronic Kidney DiseaseCortney Bosworth, Laura Kooienga, Jessica Kendrick, Gerard Smits, and Michel ChoncholUniversity of Colorado Health Sciences Center, Denver, CO

34 Adjustment for Exposure History and Important Confounders Markedly Attenuates ElevatedMortality Risk Associated With Epoetin Alfa (EPO) DoseBradbury BD,1 Do T,1 Rothman KJ,2 Critchlow CW,1 Collins A,3 Brookhart MA,4 Krishnan M,1

and Acquavella JF1

1Amgen Inc, Thousand Oaks, CA; 2Research Triangle Institute, Research Triangle, NC; 3ChronicDisease Research Group, Minneapolis, MN; 4Div. of Pharmacoepidemiology, Harvard University,Boston, MA

37 Inpatient Use of Erythropoiesis Stimulating Agents (ESA) Among Commercially-Insured DialysisPatientsDonald Brophy,1 Carolyn Harley,2 Benjamin Chastek,2 Gregory Daniel,2 Brian McNeeley,3

Matthew Gitlin,4 and Tracy J Mayne4

1Virginia Commonwealth Univ, Richmond, VA; 2i3 Innovus, Eden Prairie, MN; 3HealthCore, Inc,Wilmington, DE, 4Amgen Inc, Thousand Oaks, CA

49 Participant Follow-Up in the Kidney Early Evaluation Program (KEEP) After Initial DetectionAllan J. Collins,1 Suying Li,1 and Shu-Cheng Chen1

1Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, MN

1

1

1

1

1

1


51 Screening Practices for Chronic Kidney Disease (CKD) in South CarolinaKeidre J Corbett, B.Egan, and J.ChenMedical University of South Carolina, Charleston, SC

64 Association Between Sinus Histiocytosis And Renal Cell Carcinoma: A Case SeriesZiad El-Zoghby and Nelson LeungDepartment of Medicine, Division of Nephrology, Mayo Clinic, Rochester, MN

89 Identification of Patients with CKD Using Medicare Data: Inpatient vs. Outpatient ClaimsDavid T. Gilbertson,1 Tricia Roberts,1 Thomas Arneson,1 Stephan Dunning,1 Allan Collins,1 andBrian Bradbury2

1Chronic Disease Research Group, Minneapolis, MN; 2Amgen Inc, Thousand Oaks, CA

90 The Impact on the US Blood Supply of Blood Transfusions in DialysisGitlin M, Hollenbeak C, and Mayne TJAmgen Inc, Thousand Oaks, CA; Pennsylvania State University College of Medicine,Hershey, PA

93 Increased Use of Specific CKD Staging Codes from 2004 to 2006Daniel Halevy, Iver Juster, Yunfeng Li, Madhavi Vemireddy, and Greg Steinberg

03 Outcomes of Cultural Competency Based Patient Empowerment during Implementation of CKDClinic Model of Diabetes ManagementVipin Jain, J. Sevilla, and T. ZollingerIndianapolis, IN

07 A Review of the Effect of Epoetin Alfa on Exercise Tolerance and Physical FunctioningJansen JP,1 Evans CE,1 Guyot P,1 and Mayne TJ2

1Mapi Values; 2Amgen Inc

11 The Kidney Early Evaluation Program: Program Design and Demographic CharacteristicsClaudine Jurkovitz,1 Yang Qiu,2 Changchun Wang,2 and Wendy Brown3

1Christiana Care Center for Outcomes Research, Christiana Care Health System, Newark, DE;2Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis,MN; 3Jesse Brown Veterans Administration Medical Center, Chicago, IL

19 25-Hydroxyvitamin D and Inflammation and Its Association with Hemoglobin Levels in ChronicKidney DiseaseJessica Kendrick, Gerard Smits, and Michel ChoncholUniversity of Colorado Health Sciences Center, Denver, CO

20 25-Hydroxyvitamin D, Cardiovascular Disease and Kidney Function in the Third National Healthand Nutrition Examination SurveyJessica Kendrick, Gerard Smits, and Michel ChoncholUniversity of Colorado Health Sciences Center, Denver, CO

22 Use of Epoetin Alfa In Maintaning Hemoglobin Control Through A Software-Based ManagementTool In A Community Nephrology SettingCraig Kleinmann,1 Kathy Welch,2 Brahim K. Bookhart,3 Samir H. Mody,3 Robert Bailey,3 andJames Jackson4

1Nephrology Associates, Mobile, AL; 2Coastal Clinical Research, Inc, Mobile, AL; 3Ortho Biotech
Products, L.P., Bridgewater, NJ; 4Xcenda, Palm Harbor, FL

1

1

1

1

1

1

2

2

2

2


39 Depression in the Chronic Kidney Disease (CKD) Population and Its Association withInflammatory MarkersFrederick Lee, Patricia Dubbert, Kent Kirchner, Monique Moxey, Anita Basu, and GeetaGyamlaniNephrology Division, G.V. (Sonny) Montgomery Veterans Affairs Medical Center, Jackson, MS;University of Mississippi Medical Center, Jackson, MS

51 Uric Acid and Long-Term Outcomes in Chronic Kidney DiseaseMagdalena Madero, Mark Sarnak, Tom Greene, Allan Collins, Gerald Beck, Tom Greene, JohnKusek, Andrew Levey, and Vandana MenonTufts-New England Medical Center, Boston, MA

52 Survival of Patients Commencing Renal Replacement Therapy at Age 70 And AboveRoshan Mainali, Martha Kitchen, Wendy Baker, James Hartle, Evan Norfolk, Michael Schultz,William DiFilippo, Rajesh Govindasamy and Taher YahyaGeisinger Medical Center, Danville, PA

57 Health Economic Evaluation of Paricalcitol Compared To Non-Selective Vitamn D ReceptorActivator for the Treatment of Secondary Hyperparathyroidism in Chronic Kidney DiseasePatients: US PerspectiveMark Nuijten,1 Dennis L. Andress,2 Steven E. Marx,2 and Raimund Sterz2

1Ars Accessus Medica, Erasmus University, Rotterdam, The Netherlands; 2Abbott, Abbott Park, IL

77 A Reanalysis of The Canadian Erythropoietin Study Group (CESG) Patient-Reported Outcomes(PRO) TrialMuirhead N, Keown P, Gitlin M, Mayne TJ, and Churchill DNUWO, CAN. UBC, CAN. Amgen, USA; Amgen, CAN

92 Initial School Urinalysis Screening In the Republic of PalauSatoshi Ogata, Tsuyoshi Kobayashi, Kojiro Koyama, Masahiro Mori, Satoru Matsuki, andYorimitsu TatsukawaDepartment of Internal Medicine, Sanyo Hospital, Hiroshima, Japan

00 Trends in Coronary Artery Bypass Graft Surgery among ESRD PatientsDipen S Parikh, Madhav Swaminathan, Laura E Archer, Jula K Inrig, Lynda A Szczech, Andrew DShaw, and Uptal D PatelDuke Univ Med Ctr, Durham, NC

07 Prevalent Components of Cardiometabolic Syndrome and Cardiovascular Disease from theKidney Early Evaluation Program (KEEP)BS Pavey,1 G Saab,1 SI McFarlane,2 JR Sowers,1 S Chen,3 S Li,3 J Vaselotti,4 A Collins,3 KNorris,5 P McCullough,6 G Bakris,7 and A Whaley-Connell11University of Missouri-Columbia School of Medicine, Columbia, MO; 2State University of NewYork-Downstate, Brooklyn, NY; 3Chronic Disease Research Group, Minneapolis MedicalResearch Foundation; 4Mount Sinai School of Medicine; 5 Charles Drew University and DavidGeffen School of Medicine, University of California Los Angeles, CA; 6William BeaumontHospital, Detroit, MI; 7University of Chicago School of Medicine, Illinois, Chicago, IL

22 Metabolic Syndrome in U.S. Adults Increases with Decreased GFR: Results from Nhanes Surveys(2001-2004)James F. Reed III and Nelson P. Kopyt

23 Peripheral Arterial Disease in U.S. Adults with Metabolic Syndrome Increases with DecreasedGFR: Results from Nhanes Surveys (2001-2004)
James F. Reed III and Nelson P. Kopyt

2

2

2

2

2

2

2

2

2

2


29 Effect of Treatment of Vitamin D Deficency/ Insuffiency (VDDI) On Mineral Metabolism inNon-Dialyzed Patients with CKD (ND-CKD)Sudheer Sankar, Abdul Abdellatif, Zakaria Hamdan, John Gelfond, Fang-Ying Lin and WajehQunibiDept of Medicine, University of Texas Health Science Center, San Antonio, TX

37 Prevalence and Progression of Chronic Kidney Disease among Different RacesSamir N. Shah, Bernadette Thomas, Jamie Hirsch, Thomas Hostetter, and Michal L. MelamedAlbert Einstein College of Medicine, Bronx, NY

45 Bias Introduced By Hospitalization Events When Analyzing EPO Dosing PatternsCraig Solid,1 Dave Gilbertson,1 Stephan Dunning,1 Brian Bradburry,2 Tom Arneson,1 and AllanCollins1

1Chronic Disease Research Group, Minneapolis, MN; 2Amgen, CA

47 Perceptions Regarding Optimal Frequency of Dialysis-Based Physician (MD) Visits In ESRD:Results of a National Provider SurveyAmar Desai, Roger Bolus, Allen Nissenson, Sally Bolus, Matt Solomon, Osman Khawar, JenniferTalley, and Brennan SpiegelWest L.A. VA; UCLA

48 Perceptions Regarding Optimal Frequency of Dialysis Multidisciplinary Care Conferences:Results of a National Provider SurveyAmar Desai, Roger Bolus, Allen Nissenson, Sally Bolus, Matt Solomon, Osman Khawar, JenniferTalley, and Brennan SpiegelWest L.A. VA; UCLA

55 No Consistent Vitamin D Effect on Cardiovascular Mortality across Dialysis Vintage GroupsWL St. Peter, S Li, J Liu, DT Gilbertson, TJ Arneson, and AJ CollinsChronic Disease Research Group, Minneapolis, MN

57 The Effect of Anemia in Hypertensive Patients with Chronic Kidney Disease: Hospital Costs andLength of StaySulsky S,1, Luippold RS,1 Bookhart BK,2 Corral M,2 and Piech CT2

1ENVIRON Int’l Corp, Amherst, MA; 2Ortho Biotech Products, Bridgewater, NJ

62 Community Partnered Approaches to Enhance Chronic Kidney Disease Prevention and EarlyInterventionRoberto B. Vargas,1,2 Loretta Jones,3 Chrystene Terry,4 Joel Kopple,1,5 Keith C. Norris,1,5 and theBuilding Bridges to Optimum Health World Kidney Day Los Angeles 2007 Pre-ConferenceCollaborative1Department of Internal Medicine, the David Geffen School of Medicine, UCLA; 2RANDCorporation; 3Healthy African-American Families, Los Angeles, CA; 4Charles Drew Universityof Medicine and Science; and 5Division of Nephrology, Harbor/UCLA Hospital

64 Trends in Mineral Metabolism in the Kidney Early Evaluation Program (KEEP)Joseph A. Vassalotti, Jaime Uribarri, Shu-Cheng Chen, Suying Li, Changchun Wang, Allan J.Collins, Mona S. Calvo, Adam Whaley-Connell, Keith C. Norris, Peter A. McCullough, andDennis L. Andress, on behalf of the KEEP InvestigatorsAttributions for the authors will be provided as a poster

73 Variations in Small Dialysis Organizations (SDOs) Have Implications for BundlingWhalen J, Bhat JG, Agarwal J, Boleyn DR, Gehling J, Hollenbeak C, and de Lissovoy GTri-State Dialysis, WI; Atlantic Dialysis Management, NY; Pennsylvania State Univ. College of
Medicine, PA; United BioSource Corp, MD

2

2

2

G


74 Chronic Kidney Disease in the US: KEEP and NhanesA Whaley-Connell,1 JR Sowers,1 SI McFarlane,2 LA Stevens,3 M Shlipak,4 K Norris,5,6 SC Chen,7

Y Qiu,7 C Wang,7 JA Vassalotti,8 and AJ Collins,7 on Behalf of the KEEP Investigators

75 Diabetes Mellitus in CKD: Keep and Nhanes 1999-2004A Whaley-Connell,1 JR Sowers,1 SI McFarlane,2 K Norris,3,4 SC Chen,5 S Li,5 Y Qiu,5 C Wang,5

LA Stevens,6 JA Vassalotti,7,8 A Collins,5 and KEEP Investigators1University of Missouri-Columbia School of Medicine, Columbia, MI; 2SUNY Downstate,Brooklyn, NY; 3Charles R. Drew University of Medicine and Science; 4David Geffen School ofMedicine, University of California Los Angeles, CA; 5Chronic Disease Research Group,Minneapolis Medical Research Foundation, Minneapolis, MN; 6Tufts-New England MedicalCenter, Boston, MA; 7National Kidney Foundation, New York, NY; 8Division of Nephrology,Department of Medicine, Mount Sinai School of Medicine, New York, NY

77 A Novel Approach to Controlling Markers of Metabolic Syndrome in End-Stage Renal DiseasePatientsRonald L. Wilson, Brian Shelmadine, Rodney G. Bowden, Mindy Gentile, and Daniel P. BeaversCentral Texas Nephrology Associates Waco, TX; Baylor University, Waco, TX; NutrePletionResources, Bensalem, PA

LOMERULAR DISEASE

7 Unusual Presentation of Focal Segmental Glomerulosclerosis with Acute Renal FailureManju Alex, Marco Ladino, and Ivonne Hernandez SchulmanDivision of Nephrology and Hypertension, Veterans Affairs Medical Center and University ofMiami Miller School of Medicine, Miami, FL

26 Transcriptional Analysis of IgA Nephropathy Biopsies: Towards a Molecular ClassificationCeline C Berthier,1 Vidooshi G Maru,1 Viji Nair,1 Felix Eichinger,1 Anna Henger,1 AnissaBoucherot,1,2 Maria P. Rastaldi,3 Hermann-Josef Groene,4 Clemens D. Cohen,2 MatthiasKretzler,1 and the European Renal cDNA Bank (ERCB) consortium1Internal Medicine, University of Michigan, Ann Arbor, MI; 2University of Zurich, Switzerland;3Immunopathology-Milan, Italy; 4German Cancer Research Center, Heidelberg, Germany

30 Successful Treatment of Multi-Drug Resistant FSGS with BasiliximabGlenn H. Bock, Barbara Leauber, and Kimberly CappDept of Pediatrics, Geisinger Medical Canter, Danville, PA

42 Collapsing Focal Segmental Glomerulosclerosis (FSGS) With Spontaneous Recovery of RenalFunctionMathai M Chalunkal, Richard W. Snyder, and Robert N.PursellDepartment of Nephrology, St Lukes Hospital and Health Network, Bethlehem, PA

46 HO-1 Overexpression Reduces Proteinuria in Early Glomerular Immune InjuryAlan Chu, Pu Duann, Elias Lianos, and Robert WoodJohnson University Hospital, New Brunswick, NJ

50 Rituximab: A Novel Treatment Option for Fibrillary Glomerulonephritis?Michael Collins,1 Sankar D Navaneethan,2 James Sloand,2 and Brad Rovin1

1Ohio State University, Columbus, OH; 2University of Rochester Medical Center, Rochester, NY

56 Emerging Therapies in Membranous Nephropathy - A Case SeriesAbhishek Deshmukh, Jack Kleinman, Samuel Blumenthal, Syed Hussain, and Clement J. Zablocki
VAMC Milwaukee, WI

1

1

1

1

1

1

1

2

2


78 Reversible Cause of Acute Kidney Injury in a Patient with Rapidly Progressive Glomerulonephri-tisSajid Melvin George, Son Nguyen, Jon Sweet, and Csaba KovesdyVA Medical Center, Salem, VA; Carilion Clinic, Roanoke, VA

80 An Unusual Case of Non-Crescentric IgA Nephropathy (IgAN) With Anti-Neutrophil Cytoplas-mic Antibodies (ANCA). A Case Report and Review of LiteratureManish Gera,1 R. Jeevan,1 S. Dhar,1 and C.L. Phillips2

1Int. Med. Nephrology Inc, Terre Haute, IN; 2I. U. Pathology, Indianapolis, IN

85 Venous Thromboembolism as the Initial Presentation of Primary Renal AmyloidosisMythili Ghanta, Sriranga L Bonam, Rajan Kapoor, and Anjali AcharyaJacobi Medical Center, Bronx, NY

05 Renal Manifestations of Poems SyndromeGaurav Jain and Ivan MayaDivision of Nephrology, University of Alabama at Birmingham, Birmingham, AL

28 A Case of Membranoproliferative Glomerulonephritis (MPGN) Caused By Hepatitis a VirusRaghuveer Kura, Pritika Shrivastava, Muriel Fitzsimons, and Navin VermaPenn State Milton S. Hershey Medical Center

33 Pegfilgastim Induces a Crescentic GlomerulonephritisJorge Lamarche, Alfredo Peguero, Craig Courville, AnaVelez, and Ala’a FarahatJames A. Haley Veterans Hospital and the University of South Florida, Tampa, FL

37 Steroid Resistant Minimal Change Disease Associated With Thymoma: A Case ReportRakesh Lattupalli, Quresh Khairullah, Keith Bellovich, and Joel TopfDivision of Nephrology, St John Hospital and Medical Center, Detroit, MI

41 Prolyl-3 Hydroxylase Expression in the Mouse Kidney and Developing EmbryoJennifer Lennington,1 Roy Morello,1 Ming-Ming Jiang,1 Dustin Baldridge,1 Terry Bertin,1 andBrendan Lee1,2

1Department of Molecular and Human Genetics, Baylor College of Medicine; 2Howard HughesMedical Institute

59 Pauciimune Crescentic Glomerulonephritis in Association with Myeloma Cast Nephropathy- AParaneoplastic VasculitisMunis Mattu, Wamiq Banday, Khalid Qazi, James Ryan, Isoceles Garbes, Barbara Stefanick, andThomas CumboInternal Medicine Training Program, Catholic Health System, University at Buffalo, Buffalo, NY

79 Interstitial Nephritis as The Only Renal Lesion with C-ANCA Positive Wegener’s Disease- AnUnusual Renal PresentationMuhammad Mustafa and Anjali AcharyaJacobi Medical Center, Albert Einstein College of Medicine, Bronx, NY

02 Cryoglobulinemic Vasculitis Presenting As Pulmonary Renal Syndrome in a Patient withSclerodermaShyam Parkhie, Sumeska Thavarajah, and Francesco BoinJohns Hopkins Bayview Medical Center, Baltimore, MD

16 Diffuse Infiltrative Lymhocytosis of Kidneys in a Young Woman with HIV and SLEPrabodh Ranjan, EH Anjum, H Villanueva, and J Yoo
Our Lady of Mercy Medical Center, New York Medical College, NY

2

2

2

2

2

2

2

2

2

H


20 A Transcriptomic Approach for Lupus Nephritis ClassificationPanduranga Rao,1 Celine Berthier,1 Viji Nair,1 Felix Eichinger,1 Anna Henger,1 Clemens Cohen,2

Matthias Kretzler,1 and the European renal cDNA bank (ERCB consortium)1Department of Internal Medicine, University of Michigan; 2University of Zurich-Switzerland

21 MPGN and Nephrotic Syndrome (NS) Secondary to Lyme Disease (LD)Bishal Rawal, Leon Rovner, Charuhas Thakar, and Judson PollockThe Jewish Hospital, Cincinnati, OH

35 Diffuse Alveolar Hemorrhage in a Patient with Hepatitis C-Associated Mixed Cryoglobulinemiaand MPO-ANCA Positive Focal Segmental Necrotizing GlomerulonephritisShahzad Shafique and Ammar AlmehmiDivision of Nephrology, University of Kansas Medical Center, KS

38 Type 1 Membranoproliferative Glomerulonephritis (MPGN) in HIV without Hepatitis C (Hep C)Co Infection with Rapid Remission with Steroids and Angiotensin Converting Enzyme Inhibitors(ACEI) Without Highly Active Anti Retroviral Therapy (HAART)Simi Shahabdeen, Frederick S Fleszler, and Dianna C FalkowitzMercy Catholic Medical Center, Darby, PA

41 Successful Treatment of Henoch-Schonlein Purpura Nephritis with Plasma Exchange in an AdultMaleJi Young Shin,1 Mandeep Singh,1 and Kunal Chaudhary1,2

1Dept. of Medicine, University of Missouri Health Sciences Center; 2Harry S Truman VeteransAdministration Hospital, Columbia, MI

44 Bleeding Risk of Percutaneous Renal Biopsy in Patients with AmyloidosisSandra M. Soares, Donna J. Lager, Morie A Gertz, Fernando C. Fervenza, and Nelson LeungMayo Clinic, Rochester, MN

63 Mycophenolate Mofetil (MMF) as a First Line Agent in the Treatment of the Glomerular TipLesion of Focal Segmental Glomerulosclerosis (FSGS)Nicholas Varvarelis and Richard SnyderLehigh Valley Hospital Health Network, Allentown, PA

76 Membranous Glomerulonephritis in a Patient with A CD4�/CD56� Hematodermic NeoplasmGrady M. Wick, Suman Setty, April Brooks, Sujata Gaitonde, Amishi Patel, Christian Sebat,Damiano Rondelli, Jerrold S. Levine, and Kalyani PerumalUniversity of Illinois at Chicago College of Medicine, Chicago, IL

82 Minimal Change Disease in Association with Kikuchi-Fujimoto Disease: First Case ReportPraveen R. Yalamanchili, Sumanth Daram, and Hima Boppidi

EMODIALYSIS: ANEMIA

4 Factors Associated With Erythropoiesisstimulating Agent (ESA) Dose Requirements andHemoglobin (Hb) Response in Hemodialysis (HD) Patients: Baseline (Bl) Data from aProspective Observational RegistryIrene Agodoa, Jessica Droge, Xiang Ling, and Mahesh KrishnanAmgen Inc, Thousand Oaks, CA

19 The Effect of Baseline Estimated Glomerular Filtration Rate (eGFR) and Diabetic Status on theEfficacy of Darbepoetin Alfa in Subjects with Chronic Kidney Disease (CKD)Paul Audhya, Debra Scarlata, and R Kewalramani
Amgen Inc, Thousand Oaks, CA

1

1

1

2

2


28 Efficacy of Darbepoetin Alfa (DA) in Hemodialysis (HD) PatientsSaroj Bhat, Kim Nguyen, Jerry Yee, Anatole Besarab, William Poirier, Stanley Frinak, andJennifer HolcombHenry Ford Health Systems, Detroit, MI

75 Hemoglobin SC Disease in Chronic Kidney Disease Stage III, IV and Rare ESRD Require CloseMonitoring of Hemoglobin and Frequent Titration of Erythropoietin to Avoid Crisis and AnginaJasjot Garcha, Kyle Knuppel, Allan B Schwartz, Ziauddin Ahmed, and Allen Friedman*Drexel University College of Medicine; *Albert Einstein Medical Center, Philadelphia, PA

81 A Prospective, Case-Controlled Study of the Effect of Continuous Hemoglobin (Hgb) Monitoring(Critline) on Hemoglobin Variability (HV) and Erythropoietin (EPO) DosingMichael J Germain,1 Warren Ho,1 Jane Garb,1 Cherry Bartlett,2 and Eric Will21Baystate Medical Center, Springfield, MA; 2Media Innovations, Leeds, UK

82 Continuous Hematocrit (HCT) During Dialysis. Relationship of Max HCT (MH)To Final HCT(FH)Michael Germain,1 Brian H Nathanson,2 and Susan Pickard1

1Baystate Medical Center, Springfield, MA; 2Optistatim LLC, Longmeadow, MA

83 Frequent Hemoglobin (Hgb) Monitoring (12x/Month) Can Inform Clinical and OrganisationalDecision MakingMichael J Germain,1 Warren Ho,1 Jane Garb,1 Cherry Bartlett,2 and Eric Will21Baystate Medical Center, Springfield, MA; 2University of Leeds, Leeds, England

84 Interim Evaluation of Long-Term Safety and Tolerability of Hematide™ During MaintenanceTreatment of Anemia in Patients with CKD on HemodialysisR Geronemus, M Kaplan, P Pergola, B Schiller, F Whittier, S Wright, R Zabaneh, S Zeig,AM Duliege, R Leong, and A Besarab, for the AFX01-09 Study Group

61 Epoetin Alfa (EPO) Exhibits a Linear Response Relationship Between Achieved Hemoglobin(Hb) & Exercise ToleranceMayne TJ, Lei L, and Gitlin, MAmgen, Thousand Oaks, CA

83 Profiles of Serum Ferritin and Transferrin Saturation Following Administration of Two IV IronFormulations to Hemodialysis PatientsTimothy NguyenHoly Name Hospital, Teaneck, NJ

87 Comparison of Dosage Pattern of Erytrhopoetin Stimulating Agents with Recommended Dose inHospitalized PatientsFazle Noor, Utpal Dutta, Bashar Al Alao, Simi Shahabdeen, and Ziauddin AhmedDrexel University, College of Medicine, Division of Nephrology, Philadelphia, PA

04 Route of Epoetin Administrtion and Hemoglobin Variability In Hemodialysis PatientsTejas Patel,1 Angie Hirter,2 James Kaufman,3 Sai Ram Keithi-Reddy,1 Domenic Reda,2 and Ajay Singh1

1Brigham and Women’s Hospital, Boston, MA; 2Hines VA Hospital, Hines, IL; 3Boston VAHospital, Boston, MA

12 FG2216, A Novel Oral HIF-PHI, Stimulates Erythropoiesis and Increases Hemoglobin Concentra-tion in Patients with Non-Dialysis CKDR Provenzano,1 G Fadda,2 M Bernardo,3 C James,4 G Kochendoerfer,4 T Lee,4 S Nakayama,4 TNeff,4 and BA Piper4

1St John Hospital & Medical Center, Detroit, MI, 2California Institute of Renal Research, San
Diego, CA, 3Southwest Houston Research, Houston, TX, 4FibroGen, Inc, So San Francisco, CA

2

2

2

H

1


25 Effect of Glycemic Control on Erythropoiesis Stimulating Agent Requirement in DiabeticMaintenance Hemodialysis PatientsLon Sadowsky, S. Subramanian, D. Chewaproug, S. Aure, I. Dissanayake, and R. RajaAlbert Einstein Medical Center, Philadelphia, PA

72 Variability or Comorbidity? Evidence for a Null Effect of Hemoglobin Variability on Mortality inHemodialysis (HD) PatientsEric Weinhandl,1 David Gilbertson,1 James Ebben,1 and Allan Collins1

Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, MN

84 Clinical Performance Measure (CPM) for Anemia Based on Actual Hemoglobin (Hb) Distribu-tions in KY, IN, IL, AND OHSyed Zaidi and Michael BrierUniversity of Louisville, Louisville, KY

EMODIALYSIS: BONE AND MINERAL METABOLISM

15 Activated Vitamin D Therapy for Patients with End Stage Renal Disease on Hemodialysis: ACost-Utility Comparison of Empiric versus Usual Care StrategiesCharles B. Arbogast, Stephen W. Olson, and Robert M. PerkinsWashington, DC

16 Spontaneous Bilateral Rupture of Quadriceps Tendon in a Dialysis Patient with SecondaryHyperparathyroidismRobin Arora and Saud JavedJames J Peters VA Medical Center, Bronx, NY

40 Relationship of Calcium Intake with Serum Calcium LevelFiona Byrne, Sinead Kinsella, and JA EustaceCork University Hospital, Cork, Ireland

63 Use of Behavioral Modeling in Patient-Tailored Education on Phosphorous ControlHafez Elzein and Sana GhaddarWael Shamseddine American University of Beirut, Beirut, Lebanon

87 Active Vitamin D Analogues Do Not Directly Affect Vascular Smooth Muscle Cell Calcification,but Induce a Procalcific to Anticalcific Paracrine Switch in Co-Cultured Human MacrophagesCecilia M. Giachelli, Xianwu Li, Mohga El-AbbadiUniversity of Washington, Seattle, WA

95 “Phosgraph”: A Novel Method of Improving Patient Compliance and Phosphate Control byEducation And CompetitionHarnett PR, Ramlan G, Chandrasekaren L, Jones M, and Almond MK

97 Converting From Paricalcitol Injection to Doxercalciferol Capsules in CKD Patients on HD: ARandomized, Open-Label Study to Determine Clinically Appropriate DosesJ. Hertel, S. Hariachar, and A. GonzalezNephrology Associates, Augusta GA; Outcomes Research International, Hudson, FL; RenalEndocrine Associates, P.C., Pittsburgh, PA

15 Converting From Doxercalciferol Injection to Doxercalciferol Capsules in CKD Patients on HD:A Randomized, Open-Label Study to Determine Clinically Appropriate DosesK. Shashi Kant, Marializa Bernardo, and Alejandro R. GonzalezUniversity of Cincinnati College of Medicine, Cincinnati, OH; Southwest Houston Research, LTD,
Houston, TX; Renal Endocrine Associates, P.C., Pittsburgh, PA

1

1

1

1

1

1

2

H


17 Open Label, Placebo-Controlled, Randomized, Single Dose Escalation and Repeat Dose Study ofIntravenous CTA018 in Healthy VolunteersJukka Karjalainen,1 Jeffery Warren,1 Joel Z Melnick,1 and Jonathan Willmer2 1

Cytochroma Inc, Markham, Ontario, Canada; 2CANTEST Clinical Research, Vancouver, BritishColumbia, Canada

26 Fatal Calciphylaxis in a Hemodialysis Dependant 51y/o Female with ESRD Due to DiabeticNephropathyJagan Kothapally, David C. Yoburn, and Jeffrey ClementMemorial Hospital of Rhode Island, Pawtucket, RI

31 Medical Costs of Chronic Kidney Disease in Patients with Diabetes: A Managed Care PerspectiveFrançois Laliberté,1 Brahim Bookhart,2 Francis Vekeman,1 Mitra Corral,2 Mei-Sheng Duh,3

Robert A. Bailey,2 and Patrick Lefebvre1

1Groupe d’analyse, Ltée, Montréal, Québec, Canada; 2Ortho Biotech Clinical Affairs, LLC,Bridgewater, NJ; 3Analysis Group, Inc, Boston, MA

42 Effects of Use Patterns of Intravenous Vitamin D on All-Cause Mortality in PrevalentHemodialysis PatientsShuling Li, Wendy L St. Peter, Jiannong Liu, David T. Gilbertson, Tom J Arneson, and Allan J CollinsChronic Disease Research Group, Minneapolis, MN

74 Association of HCO3 and Phosphate with PTH Levels (iPTH, CAP, CIP and tPTH) In aHemodialysis CohortMohan S, Cheng JT, Pogue VA, and Park CMDept of Medicine, Harlem Hospital Center, Columbia University, New York, NY

75 Ethnic Differences in PTH and Mineral Metabolism in Patients Receiving Chronic HemodialysisMohan S, Cheng JT, Pogue VA, and Park CMDept of Medicine, Harlem Hospital Center, Columbia University, New York, NY

39 Coronary Artery Calcium Score, Inflammation and Mortality in Maintenance HemodialysisPatientsRonney Shantouf,1 Naser Ahmadi,3 Mehdi Rambod,1 Ferdinand Flores,3 Jima Tiano,3 MatthewBudoff,3 and Kamyar Kalantar-Zadeh1,2

1Harold Simmons Center for Kidney Disease Research& Epidemiology, 2Division of Nephrology,and 3Cardiology, LABioMed at Harbor-UCLA, Torrance, CA

EMODIALYSIS: OTHER

1 Evaluation of Factors Affecting the Adequacy of Hemodialysis in Acute SettingMersema Abate, Siddharth Bhatt, Davinder Wadehra, and Nand K WadhwaDivision of Nephrology, SUNY, Stony Brook, NY

21 Effect of Ultrafiltration on Aortic Augmentation Pressure and Index in Patients on MaintenanceHemodialysisShaun Aure, Elizabeth Gersbach, Madhu Kandarpa, Lon Sadowsky, Daranee Chewaproug, CraigOliner, William Gaughan, Imara Dissanayake, and Eric BloomAlbert Einstein Medical Center, Philadelphia, PA

24 Resolution of Cast Nephropathy Following Free Light Chain Removal by Hemodialysis in aPatient with Multiple MyelomaKolitha Basnayake,1 Colin Hutchison,1 Dia Kamel,1 Michael Sheaff,2 Neil Ashman,2 HeatherOakervee,2 Mark Cook,1 Arthur Bradwell,3 and Paul Cockwell11Queen Elizabeth Hospital, Birmingham; 2Barts and the London NHS Trust, London; 3University
of Birmingham, Birmingham, UK

1


35 Factors Associated With Sudden Cardiac Death in Chronic Hemodialysis PatientsGregory Braden, Eliah Munyikwa, Anthony Poindexter, Kenneth Santiago, and Jane GarbBaystate Medical Center/Tufts University School of Medicine, Springfield, MA

39 Testicular Angina on Dialysis: A Novel Presentation While Establishing Dry WeightBuffington, Mary, Sequeira, Adrian, Isaac, Prasanna, and Bahta, Elias

47 Impact of a Social Support Group Intervention in ESRD PatientsScott D. Cohen,1 Brenna Clougherty,2 Prashant Khetpal,1 Sholey Argani,3 Gloria Wiggs,3 Rolf A.Peterson,4 Paul L. Kimmel11Division of Renal Diseases and Hypertension, Department of Medicine, George WashingtonUniversity; 2George Washington University School of Medicine; 3Washington DC VA MedicalCenter, Renal Section; 4George Washington University, Psychology

48 A Retrospective Review of Perioperative Management of Serum Potassium Measurements inChronic Hemodialysis PatientsClenton Coleman, Harminder Sandhu, and Maria DevitaLenox Hill Hospital Department of Nephrology, New York, NY

57 Hypoalbuminemia Severity Predicts Intradialytic Parenteral Nutrition (IDPN) Effectiveness inHemodialysis PatientsArezu Dezfuli,1 Michelle Ricker,2 Deborah Scholl,2 Stanley M Lindenfeld,2 and KamyarKalantar-Zadeh1,2

1Harold Simmons Center for Kidney Disease Research & Epidemiology, Harbor-UCLA,Torrance, CA; 2Pentec Health, Boothwyn, PA

60 Mortality Trend of Hemodialysis Chains in the USA: 1996-2004Uyen Duong,1,2 Kamyar Kalantar-Zadeh,1,2 Csaba Kovesdy,3 and Rajnish Mehrotra2

1Harold Simmons Center for Kidney Disease Research & Epidemiology; 2Division of Nephrology,LABioMed at Harbor-UCLA, Torrance, CA; 3VA, Salem, VA

67 Acute Hepatitis B Infection in a Hemodialysis Patient Despite Persistent Natural ImmunityJennifer Ennis and Nicole StankusUniversity of Chicago Medical Center, Chicago, IL

69 Potential Interaction Between Midodrine and LinezolidRamy Fayad, Jerry Yee, and Nizar AttallahDivision of Nephrology and Hypertension, Henry Ford Hospital, Detroit, MI

98 Estimation of Eptifibatide Clearance by Dialysis Using an In Vitro SystemJoanna Q. Hudson,1,2 Christie A. Green,2 Elizabeth A. Beach,1 and Lisa K Jennings2

University of TN Departments of Clinical Pharmacy and Medicine, Memphis, TN

99 Predicting Drug Removal by Dialysis Using an In Vitro SystemJoanna Q. Hudson and Elizabeth A. BeachUniversity of TN Department of Clinical Pharmacy, Memphis, TN

01 High Renal Recovery Rate from Cast Nephropathy Following Free Light Chain RemovalHemodialysisColin A Hutchison,1 Kolitha Basnayake,1 Mark Cook,2 Paul Cockwell,1 and Arthur R. Bradwell3

Departments of 1Renal Medicine and 3Hematology, Queen Elizabeth Hospital, QEMC, Birming-ham, UK; 2Division of Immunity and Infection, Medical School, University of Birmingham,
Birmingham, UK

1

1

1

1

1

1

1

1

1

1


09 Inaccuracy of Blood Pressure (BP) Measurements (Mm) Before Hemodialysis (HD) Treatments(RX)Paul G. Jenkins and Marilyn NuensARA Milwaukee Dialysis Center, Milwaukee, WI

18 Homocysteine Lowering Effect of Adsorptive Dialysis Membranes: A Multicenter, Randomized,Open StudyAmir Kazory*, Marc Kribs, Véronique Fournier, Gérard Motte, Claude Guy, Nadège Devillard,Maria Yannaraki, Gilbert Zanetta, Jean-Marc Chalopin, Véronique Fayol, Didier Ducloux**Department of Nephrology, Dialysis, and Renal Transplantation, University of Franche-Comté,Besançon, France

27 No Improvement in Creatinine Despite Dialysis When PoisonedJayapriya Krishnaswamy, M. Atiq Dada, and Nancy AdamsUniversity of Connecticut Health Center, Division of Nephrology, Farmington, CT

47 Assessment of Extracellular Fluid Volume in Hemodialysis Patients by Using Calf BioimpedanceSpectroscopyLi Liu, Jochen Raimann, Grzegorz Wystrychowski, Shaunak Dwivedi, Fansan Zhu, Peter Kotanko,and Nathan W. LevinRenal Research Institute, New York, NY

48 Increasing the Clearance of Protein-Bound Solutes by Increasing Dialyzer Mass Transfer AreaCoefficient (KoA) and Dialysate Flow (Qd)Frank Luo, Kajal Patel, Natalie Recht, and Timothy MeyerStanford University and VA Palo Alto HCS, Stanford, CA

66 Pulmonary Hypertension in an Inner City ESRD Population on Hemodialysis: Prevalence, RiskFactors for, and Associations with MortalityMeyer A, Turner J, Melamed M, Hostetter T, and Raff AAlbert Einstein College of Medicine, Bronx, NY

68 Time-Dependent Association Between Dialysis Dose and 5-Year Survival in ContemporaryMaintenance Hemodialysis PatientsJessica E Miller,1 Elani Streja,1 Csaba Kovesdy,3 Charles J McAllister,4 David Van Wyck,4 Joel DKopple,2 and Kamyar Kalantar-Zadeh1,2

1Harold Simmons Center for Kidney Disease Research & Epidemiology; 2Harbor-UCLA,Torrance, CA; 3VA, Salem, VA; 4DaVita, El Segundo, CA

70 Serum Fructosamine (SF) and Glycosylated Hemoglobin (HbA1C) As Predictors Of Hospitaliza-tion And Infection In Diabetic Hemodialysis Patients (PTS)Neal Mittman, Hiteshkumar Kapupara, Namrita Baveja, Irfan Fazil, Brinda Desiraju, andMorrell M. AvramAvram Division of Nephrology, Long Island College Hospital, Brooklyn, NY

76 Association Between Inflamation and Malnutrition in Hemodialysis (HD) PatientsMoreira, PR, Librelotto CS, Bundchen PL, Rosa DF, Sperotto RL, Ticiane R, Sturmer G, andRizzi CCruz Alta University, Brazil

78 Management and Toxicokinetics of Metformin Associated Lactic Acidosis (MALA) By Continu-ous Venovenous Hemodiafiltration (CVVHDF)Mujtaba M, Madhrira M, Agarwala R, Mohan S, Park C, Anderson H, Pogue V, and Cheng JT
Harlem Hospital Center, Columbia University, NY

1

1

2

2

2

2

2

2

2

2

H


89 Hemodialysis Nonadherence: Bimodal Seasonal Variation in Attendance at an Urban CenterChamberlain I. Obialo,1 Khalid Bashir,1 Sharon Goring,2 Judith Alexander-Squires,2 BeverlyRobinson,2 and Alexander Quarshie3

1Renal and 3Biostatistics Section, Morehouse School of Medicine, Atlanta, GA; 2Dialysis ClinicsInc, Atlanta, GA

99 Combined Effects of Iron and Gadolinium as a Risk Factor for the Development of NephrogenicSystemic FibrosisMandip Panesar, Frank Boateng, Syed Masood, Munis Mattu, and Brian MurrayUniversity at Buffalo, Buffalo, NY

06 A Case of Extreme Metabolic Alkalosis in Hemodialysis PatientMinesh Pathak, Lajos Zsom, Tibor FulopUniversity of Mississippi Medical Center, Jackson, MI

14 Serum-Conductivity Impacts Bioimpedance Spectroscopy (BIS)J. Raimann, L. Liu, AT. Morris, F. Zhu, P. Kotanko, and N. Levin

15 Mortality Predictability of Serum Prealbumin in Maintenance Hemodialysis Patients in a 5-YearCohortMehdi Rambod,1 Csaba P Kovesdy,3 Joel D Kopple,2 and Kamyar Kalantar-Zadeh1,2

1Harold Simmons Center for Kidney Disease Research & Epidemiology; 2Division of Nephrology,LABioMed at Harbor-UCLA, Torrance, CA; and 3VA Med. Center, Salem, VA

53 Removal of Advanced Glycation End Products with a Novel Extracorporeal BioadsorbentReduces the Monocyte Inflammatory ResponseStuart M. Sprague, Elaine Zhang, Cynthia Daniels, and Guillermo AmeerNorthwestern University and Evanston Northwestern Healthcare, Evanston, IL

56 Does Nutrition And Inflammation Status Account For Greater Survival In Black MaintenanceHemodialysis Patients?Elani Streja,1 Rulin Cai Hechter,1 Csaba Kovesdy,3 John Robertson,4 Charles J McAllister,4 JoelD Kopple,2 and Kamyar Kalantar-Zadeh1,2

1Harold Simmons Center for Kidney Disease Research & Epidemiology; 2Harbor-UCLA,Torrance,CA; 3VA, Salem,VA; 4DaVita, El Segundo,CA

59 Hepatitis C Virus (HCV) Transmission in the Hemodialysis Setting: Importance of InfectionControl Practices and Aseptic TechniqueNicola Thompson and Stephanie BialekCDC, Atlanta, GA

70 Optimal Time of Blood Sampling For PT/PTT/INR in Hemodialysis Patients with CatheterLocked With Heparin or CitrateDavinder Wadehra, Ajay Patel, Mersema Abate, Heesuck Suh, and Nand K WadhwaDivision of Nephrology, SUNY, Stony Brook, NY

78 Interaction of Race and Obesity on the Short-Term Survival of ESRD PatientsRoderic Woodson, Janice Lea, and William McClellanEmory University, Atlanta, GA

EMODIALYSIS: VASCULAR ACCESS

20 Effect of Different Types of Access on Changes in Aortic Augmentation Pressure and Index in aSingle Hemodialysis SessionShaun Aure, Elizabeth Gersbach, Srinivas Subramanian, Lon Sadowsky, Daranee Chewaproug,Craig Oliner, William Gaughan, Imara Dissanayake, and Eric Bloom
Albert Einstein Medical Center, Philadelphia, PA

1

1

1

1

2

2

2

H

1


04 Percutaneous Thrombectomy of Arteriovenous Fistulas in Hemodialysis Patients: A Single-CenterExperienceGaurav Jain, Ivan D. Maya, and Michael AllonDivision of Nephrology, University of Alabama at Birmingham, Birmingham, AL

16 Accesss Monitoring Strategy and Long Term SurvivalSonja Kapun and Krsko, Slovenia

55 Type of Fistula, NYHA Class and Apelin, Newly Discovered Adipocytokine in HemodialyzedPatientsJolanta Malyszko, Jacek Malyszko, Piotr Kozminski, Slawomir Wolczynski, and Michal MysliwiecDepartment of Nephrology and Transplantology, Medical University, Bialystok Poland

95 Comparison of Outcomes of Transposed Upper Arm Fistulas, Brachiocephalic Fistulas, AndUpper Arm Grafts in Hemodialysis PatientsJeremy O’Neal, Ivan D. Maya, and Michael AllonDivision of Nephrology, University of Alabama at Birmingham, Birmingham, AL

08 Evaluation of Antibiotic Lock Treatment for Enterococcus Catheter Related Bacteremia inHemodialysis PatientsWilliam J. Peterson, Ivan D. Maya, and Michael AllonUniversity of Alabama at Birmingham, Division of Nephrology, Department of Medicine,Birmingham, AL

26 Use of Tunneled Catheters in HemodialysisVaibhav Sahni, Bashar Alalao, Jasjot Garcha, Joseph Saggio, and Ziauddin AhmedDrexel University College of Medicine, Philadelphia, PA

68 Ischemic Monomelic NeuropathyGautham Viswanathan and Sankar D NavaneethanMedicine, St Catherine Hospital, East Chicago, IN, and Nephrology, University of Rochester,Rochester, NY

OME DIALYSIS

31 Evaluation of the Safety of Ferumoxytol IV Iron Therapy in Peritoneal Dialysis PatientsWK Bolton,1 L Brenner,2 J Dioguardi,2 and F Finkelstein3

1Univ of VA Health System, Charlottesville, VA; 2AMAG Pharmaceuticals, Inc Cambridge, MA;3Metabolism Associates, New Haven, CT

96 Comparing Mortality of Chronic Peritoneal and Maintenance Hemodialysis Patients in the 21stCentury Up to 5 YearsRulin Cai Hechter,1 Elani Streja,1 Rajnish Mehrotra,2 Csaba Kovesdy,3 Charles J McAllister,4

John Robertson,4 Joel D Kopple,2 Jennie Jing,1 and Kamyar Kalantar-Zadeh1,2

1Harold Simmons Center for Kidney Disease Research & Epidemiology; 2Division of Nephrology,LA BioMed at Harbor-UCLA, Torrance, CA; 3VA, Salem, VA; 4DaVita, Inc, El Segundo, CA

21 Variation In Peritoneal Dialysis (PD) Utilization Among Large Dialysis Organizations (LDOS):An Explanation For PD Decrease?Osman Khawar,1,2 Kamyar Kalantar-Zadeh,1,2 Uyen Duong,1,2 Linda Fried,4 Keith Norris,2,3

Allen Nissenson,2 and Rajnish Mehrotra1,2

1LA BioMed at Harbor-UCLA, Torrance, CA; 2David Geffen School of Medicine at UCLA, LosAngeles, CA; 3Charles Drew University, Los Angeles, CA, 4VA Pittsburgh Health Care System,
Pittsburgh, PA

2

H

1

1

1

1

1

2


05 A Case of Endoscopy-Related Peritonitis in a Peritoneal Dialysis PatientMinesh Pathak and Tibor FulopUniversity of Mississippi Medical Center, Jackson, MI

YPERTENSION

5 Albuminuria in Obese Adults Is Associated With Hypertension and Sleep DisturbanceVarun Agrawal, Thomas E. Vanhecke, Barry A. Franklin, Kerstyn C. Zalesin, R. Bart Sangal, BasilHakmeh, Adam T. deJong, and Peter A. McCulloughWilliam Beaumont Hospital, Royal Oak, MI

9 Aortic Stiffness in Glomerulonephritis Chronic Kidney Disease Compared To Other CKDEtiologiesSridhar Reddy Allam, Yin Ping Liew, Susana Arrigain, Mohammed Rafey, and Martin J SchreiberCleveland Clinic Foundation, Cleveland, OH

91 Knockout of the Glucocorticoid Receptor in the Distal Nephron Does Not Affect Dexamethasone-Induced HypertensionJulie Goodwin,1 Junhui Zhang,2 and David Geller2

1Section of Nephrology, Department of Pediatrics, Yale University School of Medicine; 2Section ofNephrology, Department of Medicine, Yale University School of Medicine

67 Podocyturia in Pre-Eclampsia and Patients at High Risk for Pre-EclampsiaSamia Mian and Belinda JimUniversity of Illinois, Oak Lawn, IL

90 Biochemical Markers and Lipid Profiles in a Multiethnic Hypertensive Population from theUnited Arab EmiratesEnyioma Obineche,1 Javid Pathan,1 Rhesa Obineche,2 and Abdishakur Abdulle1

1Department of Medicine, Faculty of Medicine, UAE University; United Arab Emirates;2Comenious Medical School, Bratislava, Slovak Republic

93 Blood Pressure (BP) Control In Patients With Chronic Kidney Disease (CKD) In The Setting Of ANurse Practitioner (NP) Managed CKD Clinic ModelNaima Ogletree, Schawana Thaxton, Jerry Yee, and Sandeep SomanHenry Ford Hospital, Detroit, MI

96 Cost-Effectiveness of Aliskiren as Add on to Losartan and Optimal Antihypertensive Therapy inPatients with Type 2 Diabetes, Hypertension and Nephropathy in the UK SettingJames L Palmer,1 Veronica C Munk,2 Robert W Kotchie,3 Gabor Vincze,2 Alan Charney,4 DanielMD Tucker,1 and Lieven Annemans5

1IMS Health, Basel, Switzerland; 2Novartis Pharma AG Basel, Switzerland; 3IMS Health,London, UK; 4Novartis Pharmaceuticals Corporation, East Hanover, NJ; 5Ghent University,Ghent, Belgium

97 Smoking Associated Nodular GlomerulosclerosisAniruddha Palya, Aparna Subbaraman, Simi Shahabdeen, Dianna Falkowitz, and ShaliniVijaykumar

19 Hypertension and Chronic Kidney Disease: KEEP and NhanesMadhav V. Rao,1 Yang Oiu,2 Changchun Wang,2 and George Bakris1,3

1Department of Medicine, Section of Nephrology, University of Chicago, Pritzker School ofMedicine, Chicago, IL; 2Chronic Disease Research Group, Minneapolis Medical ResearchFoundation, Minneapolis, MN; 3Hypertensive Diseases Unit, Section of Endocrinology, Diabetes
and Metabolism, University of Chicago, Pritzker School of Medicine, Chicago, IL

2

2

2

2

2

P


24 Regulation of Calcitropic Hormone in African American with HypertensionAlicia Romero, Robert Beach, Vivien Yoon, Lori Trout, Hussein Galani, B.J. BlowUTMB, Galveston, TX

28 An Unusual Cause of Malignant HypertensionZakaria Saleem, Phillip Habib, Christopher Valentine, Ganesh Shidham, Anil AgarwalOhio State University, Columbus, OH

67 Direct Renin Inhibitor for the Treatment of Hypertension: A Systematic ReviewGautham ViswanathanMedicine, St Catherine Hospital, East Chicago, IN

69 Comparison of Ankle BP with Brachial BP Measurement in Dialysis Patients by AutomaticOscillotonometrySudhir Vyakaranam, Jayakrishnan Krishnakurup, Ravi Desi, Shah Mukhtadir, and ZiauddinAhmedDrexel University College of Medicine, Philadelphia, PA

80 Diffusion Weighted Imaging Evaluate Renal Function in Patient with Hypertension RenalDamageB.J. Xie,1 X.B. Zhang,2 and J. Zhang2

1Department of Radiology and 2Department of Surgery, Division of Urology, Renmin Hospital ofWuhan University, Wuhan, PR China

ROGRESSIVE KIDNEY DISEASE

18 Lack of Association Between Chronic Hepatitis C Virus Infection and Chronic Kidney DiseaseSumeet Asrani,1 Mark Schnitzler,2 Brett Pinsky,2 Lisa A. Rocca Rey,2,3 Fasiha Kanwal21Washington University School of Medicine, Saint Louis, MO; 2Saint Louis University School ofMedicine, Saint Louis, MO; 3University of Milan, Milan, Italy

38 Calcific Uremic Arteriolopathy (CUA) Successfully Treated with Intravenous Sodium Thiosul-phateIon D Bucaloiu,1 Evan Norfold,2 Nektarios Lountzis,3 Fred O Miller,3 and Dirk Elston3

54 Vascular Calcifications Indentified on Screening Mammography are Associated with ChronicRenal FailurePaul S. Dale, Amy Loden, Gavin Mackie, and Mike RichardsEllis Fischel Cancer Center/University of Missouri School of Medicine, Columbia, MO

59 The Management of Left Ventricular Systolic Dysfunction in Patients with Advanced ChronicKidney DiseaseVera Dounaevskaia, DiMeglio, and Ron WaldSt Michael’s Hospital, University of Toronto, Toronto, Ontario, Canada

68 Risk Factors for Accelerated Loss of GFR in Advanced Chronic Kidney Disease (CKD)Kevin Erickson, Janice Lea, William McClellan, GA, Tom Greene, Lawrence Appel, and KeithNorrisEmory University SOM, Atlanta, GA; Cleveland Clinic Foundation, Cleveland, OH; Johns
Hopkins University, Baltimore, MD; King-Drew Medical College, Los Angeles, CA

1

1

1

1

1

1

1

1


71 Chronic Kidney Disease is Significantly Underrecognized Among VA Primary Care UsersMichael Fischer,1,2 Grady Wick,1,2 Kevin Stroupe,2,3 Denise Hynes,2,4 Margaret Browning,2

Zhiping Huo,3 and James Kaufman5

1Medicine, Jesse Brown VAMC/U. Illinois, Chicago, IL; 2Center for Management of ComplexChronic Care, Hines VA, Hines, IL; 3Northwestern U., 4Medicine, Loyola U., Chicago, IL;5Medicine, Boston VAMC/Boston U., Boston, MA

72 An Innovative Strategy to Restore Renal Function in Chronic Kidney DiseaseNarisa Futrakul and Prasit FutrakulKing Chulalongkorn Memorial Hospital, Bangkok, Thailand

73 Chronic Kidney Disease as Predictor of Worse Outcomes Among Patients with CardiacInsufficiency Stages B And CArise Galil, Hélady Pinheiro, Darcília Costa and Marcus BastosNIEPEN of Federal University of Juiz de Fora and Fundação IMEPEN, Juiz de For a (MG),Brazil

02 Platelet Function Analyser-100 (PFA-100) Monitoring Does Not Predict Bleeding After Percuta-neous Kidney BiopsyBenahili Iboaya, Nahid Islam, Frederick Lee, Eric Miller, Christopher Mire, Darren Schmidt, andTibor FulopUniversity of Mississippi Medical Center, Jackson, MS

08 Calcemic Uremic Arteriolopathy -Wide Excision Is a Promising Curative Approach: Case Reportand Literature ReviewDeepak Jasuja, Thomas Powell, Alice Rocke, and Donna FineganUniversity of Pittsburgh, Pittsburgh, PA

23 Increased Risk of Peripheral Arterial Disease with Increasing Albumin/Creatine Ratio andDecreased GFRNelson P. Kopyt and James F. Reed III

24 Prevalence of Proteinuria in the U.S. Adult Population: Results from Nhanes Surveys (2001-2004)Nelson P. Kopyt and James F. Reed III

32 Nephromegaly, Interstitial Nephritis, and Common Variable ImmunodeficiencyJorge Lamarche, Alfredo Peguero, Craig Courville, Schartess Culpepper, and Luis BeltranJames A. Haley Veteran’s Hospital and University of South Florida Tampa, FL

46 Cognitive Decline, Depression and Quality of Life in Patients in Different Stages of ChronicKidney DiseaseSimone de Lima, Natália Fernandes, Fabiane dos Santos, Márcia Peruzzi, and Marcus BastosNIEPEN da UFJF e Fundação IMEPEN, Juiz de Fora (MG) - Brazil

53 Pulse Pressure as a Predictor of Chronic Kidney Disease ProgressionA. Bilal Malik, Melissa Shannon, Lavanya Amuluru, Irfan Kundi, and M. Gohar Alam.University of Arkansas for Medical Sciences and the Central Arkansas Veterans’ HealthcareSystem, Little Rock, AR

58 Prediction of Progression of Diabetic Nephropathy in a Small Set of Patients by Artificial NeuralNetworks and Proteomic AnalysisMohammad Mataria,1,2 Michael G. Janech,2 Jonas Almeida,3 Evelyn Lewis,1,2 Alison Bland,2 andJohn Arthur1, 2

1Ralph H. Johnson, VAMC, Charleston, SC; 2MUSC, Charleston, SC; 3University of Texas MD
Anderson Cancer Center, Houston, TX

1

1

1

2

2

2

2

2

2

2


82 Predictors of Late Referral after the Implementation of K-DOQI GuidelinesSankar D Navaneethan, Vinodh Jeevanantham, and Scott LiebmanNephrology, University of Rochester, Rochester, NY and Medicine, Wake Forest University,Winston-Salem, NC

94 Outcomes Associated With Hyperuricemia in Chronic Kidney DiseaseJude O Ojie, Sajid M George, Smriti Sharma, Alan Brijbassie, Kamyar Kalantar-Zadeh, andCsaba P KovesdyNephrology, Salem VA Medical Center, Salem, VA; Internal Medicine, Carilion Clinic, Roanoke,VA; Harbor-UCLA, Torrance, CA

97 Role of Renin Angiotensin System (RAS) in Anemia Related to Chronic Kidney Disease (CKD)Aniruddha Palya, Fazle Noor, Frederick Fleszler, Simi Shahabdeen, Racquel David, NiyatiModi, Sachin Shrestha, Zecharias Berhane, Ajay Kumar, Dae Hwan Kim, and Bette Seamonds

01 Relation Between Hemoglobin (Hb) And Kidney Function (eGFR) In Diabetics (DM) vs.Nondiabetics (NDM) With NephropathySreevalli Pariti,1 Timothy Poole,2 B Adams-Huet,1 and Robert Toto1

1UT Southwestern Medical Center; 2Parkland Hospital, Dallas, TX

17 Nephrotic Proteinuria In ADPKD - A Clinical ChallengePrabodh Ranjan, H Magoo, EH Anjum, C Desai, D Baumstein, A Chaudhari, and AM TannenbergMetropolitan Hospital Center, NewYork Medical College, NY

40 Treatment Patterns in Patients Progressing Through Later-Stage Chronic Kidney Disease (CKD):Baseline Data from a Prospective Observational RegistryW Shapiro,1 C Martinez,2 C Charytan,3 J Horowitz,4 D Tharpe,5 J Droge,6 X Ling,6 VBelozeroff,6 W Goodman,6 G Block,7 and S Sprague8

1Kidney Care Assoc, Brooklyn, NY; 2Renal Physicians of GA, Macon, GA; 3NY HospitalMedical Center Queens, Flushing, NY; 4Horowitz PLC, Fall River, MA; 5Nephrol Assoc,Birmingham, AL; 6Amgen, Thousand Oaks, CA; 7Denver Nephrol, Denver, CO; 8EvanstonNorthwestern Healthcare, Evanston, IL

43 Predictors of Disease Progression in Subjects with Stage 3 or 4 CKDDavid Simon,1 Fredrick Finkelstein,1 Beth Barber,2 Louis Matza,3 Rohit Borker,2 and KarenMalley4

1Metabolism Associates, P.C., New Haven, CT; 2Amgen, Inc, Thousand Oaks, CA; 3UnitedBioSource, Corp, Bethesda, MD; 4Malley Research Programming, Inc, Rockville, MD

49 Evaluation of Ferumoxytol Safety and Efficacy in All Stages of Chronic Kidney Disease (CKD)B Spinowitz,1 AT Kausz,2 J Dioguardi,2 and C Kovesdy3

1NY Hospital, Queens, NY; 2AMAG Pharmaceuticals, Inc, Cambridge, MA; 3Salem Veteran’sAffairs Medical Center, Salem, VA

50 Effects of Vitamin D on ESA Requirements in CKD Stage 3-4Stuart Sprague, Yvette Shannon, Nadia Khambati, Paulynn Katsulis, Lumi Stutz, and Louisa HoEvanston Northwestern Healthcare, NUFSOM, Evanston, IL

51 Ergocalciferol and Active Vitamin D for Hyperparathyroidism in CKDStuart M. Sprague, Louisa Ho, and Nadia Khambati
Evanston Northwestern Healthcare, NUFSOM, Evanston, IL

2

2

2

T


52 Lanthanum Carbonate Reduces Phosphate Burden In Patients With CKD Stages 3 And 4: ResultsFrom A Randomized Multicenter TrialStuart Sprague,1 William Finn,2 Hanna Abboud,3 and Ping Qiu,4 on behalf of the SPD405-206study investigators1Evanston Northwestern Healthcare, Northwestern University, Evanston, IL; 2Division ofNephrology & Hypertension, University of North Carolina Kidney Center, Chapel Hill, NC; 3

University of Texas Health Science Center at San Antonio, Medicine/ Nephrology, San Antonio,TX; 4Shire Pharmaceuticals, Wayne, PA

71 Characterizing Treatment of Stage 3 Chronic Kidney Disease (CKD) Amongst Hispanics,African-Americans (AA), and CaucasiansSalman Waheed and Rajeev RohatgiDepartment of Medicine, James J. Peters VA Medical Center, Bronx, NY

79 Apparent Diffusion Coefficient Evaluate the Recoverability of Renal Function in Patient withUnilateral Hydronephrosis after Percutaneous NephrolithotomyBaojun Xie and Xiaobin ZhangWuhan, PR China

RANSPLANTATION

17 Renal Allograft Survival Among Patients with Lupus NephritisMuhammad Ashraf, Nagaraju Sarabu, and Daniel C. BrennanSt Luke’s Hospital, Chesterfield, MO; Washington University, St Louis, MO

22 Conversion from Cyclosporine to Tacrolimus Based Immunosuppression Therapy in RenalTransplant RecipientsLars BäckmanTransplant Institute Sahlgrenska University Hospital, Gothenburg, Sweden

45 Recurrent Atypical Hemolytic Uremic Syndrome Associated With Factor I Mutation in a LivingRelated Renal Transplant RecipientMicah R. Chan, Christie P. Thomas, Richard J. Smith, Jose Torrealba, and Millie Samaniego,University of Wisconsin Hospitals and Clinics, Madison, WI; University of Iowa Hospitals andClinics, Iowa City, IA

53 Disconnect Between Beta-2 Microglobulin and Creatinine after Renal TransplantMohammed Atiq Dada, Swetha Nataraj, Sharad Sathyan, David Hull, Kory Tray, and K. VinayRanga

62 Complications of Pediatric Live-Donor Kidney Transplantation in Developing Country: SingleCenter’s Experience from EgyptAmr A El-Husseini and Mohamed A SobhUrology & Nephrology Center, Mansoura University, Egypt

70 Recurrent Membranous Lupus Nephritis in a Renal Allograft Treated With RituximabJennifer Fillaus, Troy Plumb, Clifford Miles, Gerald Groggel, Marius Florescu, and Vinaya RaoUniversity of Nebraska Medical Center, Omaha, NE

74 Heart Transplant Anti-Rejection Therapy Does Not Prevent De Novo Immune Mechanism KidneyDiseaseJasjot Garcha, Allan B. Schwartz, Nedjema Sustento-Reodica, Howard Eisen, and Shelly Hankins
Drexel University College of Medicine, Philadelphia, PA

1

1

1

1

1

1

1

1

1

2


76 A Comparative Study Of Steroid Sparing Immunosupressive Regimen With Steroid InclusiveRegimen in Renal Transplant PatientsLekha K. George, Liliana Soltero, and Horacio E. AdrogueBaylor College of Medicine, Houston, TX

86 De Novo Minimal Change Disease (MCD) Following Kidney TransplantationNimrta Ghuman, Vedavati Patel, John de Palma, Arvind Datla, Swetha Nataraj, and K. VinayRanga.Medicine/Transplantation, Hartford Hospital/UCHC, Farmington, CT

06 Diagnostic Imaging Clues and Management Of Sudden Blindness After Renal TransplantK. Janga, K. Sharma, D. Glicklich, S. Greenberg, VA. Tellis, SM. Greenstein, and RS. SchechnerMontefiore Medical Center, Bronx, NY

14 Need for Diagnostic Criteria for Antibody Mediated Rejection (AMR) in Pancreas After KidneyTransplantationSubramanian Kannan, Renu Bansal, Swetha Nataraj, Sharad Sathyan, Andrew Ricci, andK. Vinay RangaMedicine/Pathology/Transplant, Hartford Hospital/UCHC, Farmington, CT

34 De Novo Cellular Focal Segmental Glomerulosclerosis (FSGS) Associated with Sirolimus:A Case ReportRakesh Lattupalli, El Ghoroury, Darla Granger, and Hong QuDivision of Nephrology, St John Hospital Medical Center, Detroit, MI

49 Infection Patterns in HIV Positive and HIV Negative Renal Transpltan PatientsLina Mackelaite, Nauman Shahid, Iram Mahmood, Gary Xiao, Ziauddin Ahmed, and KarthikRanganna

50 Is Asymptomatic Pyuria a Risk Factor of Infectious Complications After Surveillance RenalTransplant Biopsy?Lina Mackalaite, Quingdi Geng, Karthik Ranganna, Anil Kumar, and Ziauddin Ahmed

64 De Novo Renal Cell Carcinoma after Kidney Transplantation: A Case ReportRadhika Medipalli and Ehab R SaadMedical College of Wisconsin Milwaukee, WI

69 Performance of Current Equations for Estimation of GFR in Different Stages of CKD AmongRenal Transplant RecipientsOsama El Minshawy, MD1,2 and Antonio Guasch, MD1

1Renal Division, Dept. of Medicine, Emory University; 2on Sabbatical leave from El MiniaUniversity School of Medicine, El Minia, Egypt

73 Use of Erythrocyte Stimulating Agent During Renal TransplantationNiyoti Modi, Ziauddin Ahmed, Iram Mahmood, Anil Kumar, Karthik Ranganna, and DevasmitaChowdhury

81 De Novo Focal Segmental Glomerulosclerosis (FSGS) Following Renal Transplant In A PatientWith Autosomal Dominant Polycystic Kidney Disease (ADPKD)Swetha Nataraj, Vinitha Vellanki, Atiq Dada, Fabiola Balarezo, and K. Vinay RangaMedicine/Pathology/Transplantation, Hartford Hospital/UCHC, Hartford, CT

27 Outcomes in Recipients and Donors of Commercial Kidney TransplantationImran Sajjad1 and Rahul M. Jindal21Department of Medicine, University of Wisconsin; 2Department of Surgery, Brookdale University
Hospital, Brooklyn

2

2

2

2

2

O


33 Clinical Improvement in Nephrogenic Systemic Fibrosis (NSF) Following Renal Transplantation:Should ‘NSF Points’ be Considered in Allocation?Sharad Sathyan, Swetha Nataraj, M. Atiq Dada, and K. Vinay RangaMedicine/Transplantation, Hartford Hospital/UCHC, Farmington, CT

34 Co-Existing Peritubular Capillary (PTC) Basement Membrane Lamination and PodocyteEffacement on EM in Kidney Transplant on CNI-Free RegimenSharad Sathyan, Zeeshan Khawaja, John de Palma, Mathew Brown, Anne Lally, David Hull, andK. Vinay RangaMedicine/Transplantation, Hartford Hospital/UCHC, Farmington, CT

46 Prophylaxis of Gentamicin NephrotoxicityW. Brian Somerset, Robert Gayner, Joseph Jacobs, Adam Dratch, Robert Pursell, and RichardSnyderDepartment of Nephrology, St Luke’s Hospital and Health Network, Bethlehem, PA

66 Hyperoxaluria after Bariatric Surgery in a Potential Kidney Donor May Actually Preclude KidneyDonationVinitha Vellanki, M. Atiq Dada, Sharad Satyan, Vikram Beemidi, and K. Vinay Ranga.Medicine/Transplantation, Hartford Hospital UCHC, Farmington, CT

83 Successful Living Kidney Donation after Ablation of Accessory Conducting Pathway in theDonorFaisal Zaeem, Arvind Datla, Nitesh Sood, Jeffrey Kluger, Ravi Yarlagadda, David Hull, andK. Vinay RangaMedicine/Transplantation, Hartford Hospital/UCHC, Farmington, CT

THER

3 Expanded Plasma Volume in Waldenstrom’s Macroglobulinemia as Evidenced by IGM ReductionRatios During Therapeutic Plasma Exchange (TPE)Fabio Aglieco, Renu Bansal, and Andre A. KaplanUniversity of Connecticut Health Center, Farmington, CT

6 Awareness and Knowledge of Chronic Kidney Disease Clinical Practice Guidelines AmongInternal Medicine Residents. A National SurveyVarun Agrawal, Michael A. Barnes, and Amit K. GhoshWilliam Beaumont Hospital, Royal Oak, MI; Mayo Clinic, Rochester MN

8 Estimation of GFR by MDRD Formula and Its Correlation to Cockcroft-Gault Equation in FiveStages of Chronic Kidney DiseaseAli A, Rais Z, Asif N, Adnan F, Kashif W, Merchant D, and Yaqub SAga Khan University Hospital, Dept of Medicine, Nephrology Section, and Liaquat NationalHospital, Karachi Pakistan

14 Alternating ANCA Specificity from cANCA to pANCA in a Stage 5 CKD Patient with PalpablePurpuraEhteshamul H Anjum and Hena Kausar
Saint Augustine, FL

1

1

1

1

1


41 Applying an Expanded Set of Cognitive Design Principles to Formatting the NKF Kidney EarlyEvaluation Program Longitudinal Survey (KEEP-LS)José Luis Calderón,1,2 Erik Fleming,2 Monica Gannon,3 Shu-Cheng Chen, 4 Joseph A. Vassaloti,3

and Keith C. Norris2,5

1College of Pharmacy, Health Professions Division, Nova Southeastern University, FortLauderdale, FL; 2Charles R. Drew University of Medicine and Science, Los Angeles, CA;3National Kidney Foundation, New York, NY; 4KEEP Data Coordinating Center, Minneapolis,MN; 5David Geffen School of Medicine, University of California, Los Angeles (UCLA)

58 Nephrogenic Fibrosing Dermopathy (NFD) in a Patient with Acute Kidney Injury (AKI)Ashish Dhungel, Rakesh Lattupalli, Mohammed El Ghoroury, Robert Provenzano, and Joel TopfDivision of Nephrology, St John Hospital and Medical Center, MI

61 Differential Effects of Calcitriol and Paricalcitol on Vascular Calcification in High Phosphate-Fed,Uremic MiceMohga El-Abbadi, Bryan Bartley, Cameron Gaskill, Carly Ingalls, and Cecilia M. GiachelliUniversity of Washington, Seattle, WA

66 Renal Cell Carcinoma in a 22 Year Old Patient with Sinus HistiocytosisZiad El-Zoghby and Nelson LeungDepartment of Medicine, Division of Nephrology, Mayo Clinic, Rochester, MN

92 Treatment of Sarcoid Granulomatous Interstitial Nephritis with AdalimumabRoopali Gupta, Jack Moore Jr, Lisa Beaudet, and Tulsi K MehtaDeparments of Nephrology and Pathology, Washington Hospital Center, Washington DC

10 Ultrasound versus CT-Scan Guided Kidney BiopsyAmit Joshi, Suresh Pasya, Gaurav Jain, and Peter HartSection of Nephrology, John H. Stroger Hospital of Cook County, Chicago, IL

25 Apparent Disparity in Testing of Patients with Chronic Kidney Disease (CKD), Plus DiabetesAnd/Or Hypertension and Impact of GenderEileen Koski,1 Xiaohua Huang,2 Marsha Green,1 Harvey Kaufman,3 Herman Hurwitz,4 RichardFurlanetto,5 and Joseph Vassalotti61-5Quest Diagnostics Incorporated: 1Lyndhurst NJ, 2West Norriton, PA; 3Madison, NJ; 4Philadel-pia, PA, 5Chantilly, VA, 6National Kidney Foundation and Mount Sinai School of Medicine NewYork, NY

30 Drug Utilization and Cost Considerations of Predialysis Chronic Kidney Disease PatientsReceiving Erythropoietic Stimulating Agents Through Pharmacy BenefitsFrançois Laliberté,1 Patrick Lefebvre,1 Francis Vekeman,1 Janice Lopez,2 R. Scott McKenzie,2

Brahim Bookhart,21Groupe d’analyse, Ltée, Montréal, Québec, Canada; 2Ortho Biotech Clinical Affairs, LLC,Bridgewater, NJ

35 Nephrogenic Fibrosing Dermopathy (NFD): Case Series of 3 Patients in a Single CenterRakesh Lattupalli, Ashish Dhungel, Keith Bellovich, Robert Provenzano, and Joel TopfDivision of Nephrology, St John Hospital and Medical Center, MI

40 Assessment of Drug Utilization Patterns and Costs for Erythropoietic Stimulating Agents inPatients with Chronic Kidney DiseasePatrick Lefebvre,1 François Laliberté,1 Marie-Héléne Lafeuille,1 Brahim Bookhart,2 R. ScottMcKenzie,2 Mitra Corral,2 and Catherine Piech2

1Groupe d’analyse, Ltée, Montréal, Québec, Canada; 2Ortho Biotech Clinical Affairs, LLC,
Bridgewater, NJ

1

1

1

1

1

1

2

2

2


45 Utilization of Erythropoeisis Stimulating Proteins in Hospitalized PatientsAntonio Ligon, Yin Ping Liew, Sam Butler, Julie Barnes, and Martin SchreiberCleveland Clinic, Cleveland, OH

62 Chronic Kidney Disease and Cardiovascular Disease in Volunteer and Randomly SelectedPopulations: KEEP and NhanesPeter A. McCullough,1 Suying Li,2 Claudine T. Jurkovitz,3 Lesley A. Stevens,4 Changchun Wang,2

Allan J. Collins,2 Shu-Cheng Chen,2 Keith C. Norris,5 Samy McFarlane,6 Bruce Johnson,7

Michael G. Shlipak,8 Chamberlain I. Obialo,9 Wendy W. Brown,10 Joseph A. Vassalotti,11 andAdam T. Whaley-Connell,12 on behalf of the KEEP Investigators1-10Attributions for the authors will be provided as a poster

63 Racial and Gender Differences in Prevalence and Predictors of Anemia of Chronic KidneyDisease: KEEP and Nhanes 1999-2004Samy I. McFarlane,1 Shu-Cheng Chen,2 Adam Whaley-Connell,3 James Sowers,3 Joseph A.Vassalotti,4 Moro O. Salifu,1 Suying Li,2 Changchun Wang,2 George Bakris,5 Peter McCullough,6

Allan J. Collins,2 and Keith Norris,7on behalf of the KEEP Investigators1-7Attributions for the authors will be provided as a poster

84 Calciphylaxis from Non-Uremic Etiologies: A Systematic ReviewSagar U Nigwekar and John K HixRochester General Hospital, Rochester, NY

85 Sarcoidosis “Unmasked”Sagar U Nigwekar, Bishoy Faltas, and John K HixRochester General Hospital, Rochester, NY

91 Inter-Relations Between B-Type Natriuretic Peptides & Vit D in Patients on MaintenancePeritoneal Dialysis & in Women Post-PartumEnyioma N Obineche,1 Hussain Saadi,1 Sheela Benedict,1 Javed Pathan1, Christopher MFrampton2 and M Gary Nicholls2

1Department of Internal Medicine, Faculty of Medicine & Health Sciences, UAE University, AlAin, United Arab Emirates; 2Department of Medicine & Health Sciences, Christchurch Hospital,Christchurch, New Zealand

30 Cardiovascular Events and Mortality in Chronic Kidney Disease Patients Treated With EpoetinAlfa or Darbepoetin AlfaErdal Sarac, Victor Lossev, Donald J. Misquitta, Ali Dinani, and David GemmelNortheastern Ohio Universities College of Medicine, Rootstown, OH; St Elizabeth Health Center,Youngstown, OH

32 Feasibility of Internet-Based Data Collection with People Who Have Kidney DiseaseRenee N. Saris-Baglama,1 Kimberly Clayton,2 Michelle M. Richardson,2 Monica Gannon,3 GigiPolitoski,3 Milena D. Anatchkova,1 Diane M. Turner-Bowker,1 Lesley A. Stevens,2 Dana C.Miskulin,2 Wendy Brown,3 Sheila Weiner,3 John E. Ware,1 Klemens B. Meyer2

1QualityMetric Incorporated, Lincoln, RI; 2Tufts-New England Medical Center, Boston, MA; 3

National Kidney Foundation, New York, NY

54 Standardization of Serum Creatinine and Estimated Glomerular Filtration Rate in The NationalKidney Foundation Kidney Early Evaluation Program (KEEP)Lesley A. Stevens and Nicholas Stoycheff
Tufts-New England Medical Center, Boston, MA

2

2

R

1

1

1

1

2


60 Different Toxicity on Renal Tissue between New and Old Original Intravenous Iron Preparationsin Normal RatsToblli Jorge, Cao Gabriel, Oliveri Leda, and Angerosa MargaritaLab. Experimental Medicine, Hospital Alemán, Buenos Aires

65 Survey of Driving Habits and Assessment of Risk in Dialysis PatientsHemender VatsDouglas Duffy Marshfield Clinic, Marshfield, WI

ESEARCH FELLOWS/YOUNG INVESTIGATORS

25 Functional Analysis of Human Mutations In NAPI-IIC Reveals Important Residues for SurfaceExpression and Sodium-Phosphate Co-TransportClemens Bergwitz,1 Graciana Jaureguiberry,1 Thomas O Carpenter,3 Stuart Forman,2 andHarald Jüppner1

1Endocrine Unit; 2Dept. of Anesthesiology, Massachusetts General Hospital, Boston, MA; 3Dept.of Pediatrics and Endocrine Unit, Yale School of Medicine, New Haven, CT

29 Urinary Markers for Progressive Renal FibrosisBitzer M, Shang H, Lim J, Ju W, Kopp JB, Hostetter TH, and Angeletti RHAlbert Einstein College of Medicine, Bronx, NY; Mount Sinai School of Medicine, NY, NY;NIDDK, NIH, Bethesda, MD

52 Granulogenesis in Sympathoadrenal Chromaffin Cells: Contribution of the NeuroendocrineSecretory Protein Secretogranin IIMaïté Courel,1 Daniel T. O’Connor,1,2 and Laurent Taupenot1,2

1Dept of Medicine, University of California at San Diego, La Jolla, CA; 2VASDHS, San Diego, CA

00 HD Catheters and Inflammation Are Determinants of Erythropoietin (EPO) RequirementsAdriana Hung, Edward Siew, Kerri Cavanaugh, Raymond Hakim, and Alp Ikizler VanderbiltUniversity, Nashville, TN; Veterans Administration Tennessee Valley Healthcare System, Nash-ville, TN

38 Are Vascular Access Outcomes in the Fistula First Era Affected By the Surgeon?Timmy Lee1 and Michael Allon2

1University of Cincinnati, Cincinnati, OH; 2University of Alabama at Birmingham, Birmingham,AL

60 Stent vs. Angioplasty for Treatment of Thrombosed AV Grafts: Long Term OutcomesIvan D. MayaUAB, Birmingham, AL

65 Establishing a Framework to Infer Gene Regulatory Networks for Kidney DevelopmentLuis F Menezes,1 Klaus Piontek,1 Carlo Colantuoni,2 Scott Patterson,3 Joel Bader,3 and GregoryG Germino1

1School of Medicine; 2School of Public Health; 3Biomedical Engineering, Johns HopkinsUniversity, Baltimore, MD

58 Primary Cilia Regulate cAMP-Dependent Signaling in Kidney CellsAkira Suzuki and Peter IgarashiUniversity of Texas Southwestern Medical Center, Dallas, TX

national kidney foundation 2008 spring clinical meetings

Documents